Litigation Details for Lotus Pharmaceutical Co. Ltd v. GlaxoSmithKline LLC (D. Del. 2016)
✉ Email this page to a colleague
Lotus Pharmaceutical Co. Ltd v. GlaxoSmithKline LLC (D. Del. 2016)
Docket | ⤷ Sign Up | Date Filed | 2016-05-20 |
Court | District Court, D. Delaware | Date Terminated | 2016-06-16 |
Cause | 28:1331 Fed. Question | Assigned To | Gregory Moneta Sleet |
Jury Demand | None | Referred To | |
Patents | 8,637,512; 9,144,547 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Lotus Pharmaceutical Co. Ltd v. GlaxoSmithKline LLC
Details for Lotus Pharmaceutical Co. Ltd v. GlaxoSmithKline LLC (D. Del. 2016)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
0000-00-00 | External link to document | |||
2016-05-20 | 3 | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,637,512; 9,144,547;(aah) (Entered…2016 16 June 2016 1:16-cv-00377 830 Patent None District Court, D. Delaware | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |